CDH2 and cancer: EMT process has been recognized as a key contributor in cancer cell migration and metastasis (Guarino et al. 2007), which is characterized by loss of cell adhesion, downregulation of E-cadherin expression, and acquisition of mesenchymal markers including N-cadherin and Vimentin to increase cell motility (Guarino et al. 2007).